BIO International

Sales & Marketing

At BIO2024 experts agreed that in a period where pharma is deeply unpopular, the industry must be proactive in telling its story.

R&D

This week, pharmaphorum editor-in-chief Jonah Comstock headed to not one, but two back-to-back events in the US.

News

Pressure is building on Amgen to withdraw rare disease therapy Tavneos, after the CHMP recommended its marketing authorisation by revoked in the EU.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.